0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antimicrobial Effectiveness Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-7Y17152
Home | Market Reports | Computers & Electronics| Software
Global Antimicrobial Effectiveness Testing Service Market Research Report 2024
BUY CHAPTERS

Global Antimicrobial Effectiveness Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-7Y17152
Report
November 2025
Pages:161
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antimicrobial Effectiveness Testing Service Market

The global Antimicrobial Effectiveness Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Pharmaceutical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Antimicrobial Effectiveness Testing Service leading manufacturers including Intertek, Eurofins, Almac, Steris, Aemtek, Q Laboratories, Wickham Micro, Nelson Labs, MycoScience, Reading Scientific Services, etc., dominate supply; the top five capture approximately % of global revenue, with Intertek leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Antimicrobial Effectiveness Testing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Antimicrobial Effectiveness Testing Service Market Report

Report Metric Details
Report Name Antimicrobial Effectiveness Testing Service Market
Segment by Type
  • USP Standard Testing
  • EP Standard Testing
Segment by Application
  • Pharmaceutical
  • Cosmetic
  • Cleaning Supplies
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Intertek, Eurofins, Almac, Steris, Aemtek, Q Laboratories, Wickham Micro, Nelson Labs, MycoScience, Reading Scientific Services, MSL Solution Providers, Consumer Product Testing Company, QACS, Microchem Laboratory, BioScreen, Lucideon, Microbac, Pace Life Sciences, Neopharm, Pacific BioLabs, BA Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Antimicrobial Effectiveness Testing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Antimicrobial Effectiveness Testing Service Market report?

Ans: The main players in the Antimicrobial Effectiveness Testing Service Market are Intertek, Eurofins, Almac, Steris, Aemtek, Q Laboratories, Wickham Micro, Nelson Labs, MycoScience, Reading Scientific Services, MSL Solution Providers, Consumer Product Testing Company, QACS, Microchem Laboratory, BioScreen, Lucideon, Microbac, Pace Life Sciences, Neopharm, Pacific BioLabs, BA Sciences

What are the Application segmentation covered in the Antimicrobial Effectiveness Testing Service Market report?

Ans: The Applications covered in the Antimicrobial Effectiveness Testing Service Market report are Pharmaceutical, Cosmetic, Cleaning Supplies, Others

What are the Type segmentation covered in the Antimicrobial Effectiveness Testing Service Market report?

Ans: The Types covered in the Antimicrobial Effectiveness Testing Service Market report are USP Standard Testing, EP Standard Testing

1 Study Coverage
1.1 Introduction to Antimicrobial Effectiveness Testing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Antimicrobial Effectiveness Testing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 USP Standard Testing
1.2.3 EP Standard Testing
1.3 Market Segmentation by Application
1.3.1 Global Antimicrobial Effectiveness Testing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Cosmetic
1.3.4 Cleaning Supplies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antimicrobial Effectiveness Testing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Antimicrobial Effectiveness Testing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Antimicrobial Effectiveness Testing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Antimicrobial Effectiveness Testing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 USP Standard Testing Market Size by Players
3.3.2 EP Standard Testing Market Size by Players
3.4 Global Antimicrobial Effectiveness Testing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Antimicrobial Effectiveness Testing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Antimicrobial Effectiveness Testing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Antimicrobial Effectiveness Testing Service Market Size by Type (2020-2031)
6.4 North America Antimicrobial Effectiveness Testing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Antimicrobial Effectiveness Testing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Antimicrobial Effectiveness Testing Service Market Size by Type (2020-2031)
7.4 Europe Antimicrobial Effectiveness Testing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Antimicrobial Effectiveness Testing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Antimicrobial Effectiveness Testing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Antimicrobial Effectiveness Testing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Antimicrobial Effectiveness Testing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Antimicrobial Effectiveness Testing Service Market Size by Type (2020-2031)
9.4 Central and South America Antimicrobial Effectiveness Testing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Antimicrobial Effectiveness Testing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Antimicrobial Effectiveness Testing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Antimicrobial Effectiveness Testing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Antimicrobial Effectiveness Testing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Intertek
11.1.1 Intertek Corporation Information
11.1.2 Intertek Business Overview
11.1.3 Intertek Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.1.4 Intertek Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.1.5 Intertek Antimicrobial Effectiveness Testing Service Revenue by Product in 2024
11.1.6 Intertek Antimicrobial Effectiveness Testing Service Revenue by Application in 2024
11.1.7 Intertek Antimicrobial Effectiveness Testing Service Revenue by Geographic Area in 2024
11.1.8 Intertek Antimicrobial Effectiveness Testing Service SWOT Analysis
11.1.9 Intertek Recent Developments
11.2 Eurofins
11.2.1 Eurofins Corporation Information
11.2.2 Eurofins Business Overview
11.2.3 Eurofins Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.2.4 Eurofins Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.2.5 Eurofins Antimicrobial Effectiveness Testing Service Revenue by Product in 2024
11.2.6 Eurofins Antimicrobial Effectiveness Testing Service Revenue by Application in 2024
11.2.7 Eurofins Antimicrobial Effectiveness Testing Service Revenue by Geographic Area in 2024
11.2.8 Eurofins Antimicrobial Effectiveness Testing Service SWOT Analysis
11.2.9 Eurofins Recent Developments
11.3 Almac
11.3.1 Almac Corporation Information
11.3.2 Almac Business Overview
11.3.3 Almac Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.3.4 Almac Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.3.5 Almac Antimicrobial Effectiveness Testing Service Revenue by Product in 2024
11.3.6 Almac Antimicrobial Effectiveness Testing Service Revenue by Application in 2024
11.3.7 Almac Antimicrobial Effectiveness Testing Service Revenue by Geographic Area in 2024
11.3.8 Almac Antimicrobial Effectiveness Testing Service SWOT Analysis
11.3.9 Almac Recent Developments
11.4 Steris
11.4.1 Steris Corporation Information
11.4.2 Steris Business Overview
11.4.3 Steris Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.4.4 Steris Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.4.5 Steris Antimicrobial Effectiveness Testing Service Revenue by Product in 2024
11.4.6 Steris Antimicrobial Effectiveness Testing Service Revenue by Application in 2024
11.4.7 Steris Antimicrobial Effectiveness Testing Service Revenue by Geographic Area in 2024
11.4.8 Steris Antimicrobial Effectiveness Testing Service SWOT Analysis
11.4.9 Steris Recent Developments
11.5 Aemtek
11.5.1 Aemtek Corporation Information
11.5.2 Aemtek Business Overview
11.5.3 Aemtek Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.5.4 Aemtek Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.5.5 Aemtek Antimicrobial Effectiveness Testing Service Revenue by Product in 2024
11.5.6 Aemtek Antimicrobial Effectiveness Testing Service Revenue by Application in 2024
11.5.7 Aemtek Antimicrobial Effectiveness Testing Service Revenue by Geographic Area in 2024
11.5.8 Aemtek Antimicrobial Effectiveness Testing Service SWOT Analysis
11.5.9 Aemtek Recent Developments
11.6 Q Laboratories
11.6.1 Q Laboratories Corporation Information
11.6.2 Q Laboratories Business Overview
11.6.3 Q Laboratories Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.6.4 Q Laboratories Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.6.5 Q Laboratories Recent Developments
11.7 Wickham Micro
11.7.1 Wickham Micro Corporation Information
11.7.2 Wickham Micro Business Overview
11.7.3 Wickham Micro Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.7.4 Wickham Micro Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.7.5 Wickham Micro Recent Developments
11.8 Nelson Labs
11.8.1 Nelson Labs Corporation Information
11.8.2 Nelson Labs Business Overview
11.8.3 Nelson Labs Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.8.4 Nelson Labs Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.8.5 Nelson Labs Recent Developments
11.9 MycoScience
11.9.1 MycoScience Corporation Information
11.9.2 MycoScience Business Overview
11.9.3 MycoScience Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.9.4 MycoScience Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.9.5 MycoScience Recent Developments
11.10 Reading Scientific Services
11.10.1 Reading Scientific Services Corporation Information
11.10.2 Reading Scientific Services Business Overview
11.10.3 Reading Scientific Services Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.10.4 Reading Scientific Services Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 MSL Solution Providers
11.11.1 MSL Solution Providers Corporation Information
11.11.2 MSL Solution Providers Business Overview
11.11.3 MSL Solution Providers Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.11.4 MSL Solution Providers Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.11.5 MSL Solution Providers Recent Developments
11.12 Consumer Product Testing Company
11.12.1 Consumer Product Testing Company Corporation Information
11.12.2 Consumer Product Testing Company Business Overview
11.12.3 Consumer Product Testing Company Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.12.4 Consumer Product Testing Company Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.12.5 Consumer Product Testing Company Recent Developments
11.13 QACS
11.13.1 QACS Corporation Information
11.13.2 QACS Business Overview
11.13.3 QACS Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.13.4 QACS Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.13.5 QACS Recent Developments
11.14 Microchem Laboratory
11.14.1 Microchem Laboratory Corporation Information
11.14.2 Microchem Laboratory Business Overview
11.14.3 Microchem Laboratory Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.14.4 Microchem Laboratory Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.14.5 Microchem Laboratory Recent Developments
11.15 BioScreen
11.15.1 BioScreen Corporation Information
11.15.2 BioScreen Business Overview
11.15.3 BioScreen Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.15.4 BioScreen Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.15.5 BioScreen Recent Developments
11.16 Lucideon
11.16.1 Lucideon Corporation Information
11.16.2 Lucideon Business Overview
11.16.3 Lucideon Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.16.4 Lucideon Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.16.5 Lucideon Recent Developments
11.17 Microbac
11.17.1 Microbac Corporation Information
11.17.2 Microbac Business Overview
11.17.3 Microbac Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.17.4 Microbac Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.17.5 Microbac Recent Developments
11.18 Pace Life Sciences
11.18.1 Pace Life Sciences Corporation Information
11.18.2 Pace Life Sciences Business Overview
11.18.3 Pace Life Sciences Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.18.4 Pace Life Sciences Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.18.5 Pace Life Sciences Recent Developments
11.19 Neopharm
11.19.1 Neopharm Corporation Information
11.19.2 Neopharm Business Overview
11.19.3 Neopharm Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.19.4 Neopharm Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.19.5 Neopharm Recent Developments
11.20 Pacific BioLabs
11.20.1 Pacific BioLabs Corporation Information
11.20.2 Pacific BioLabs Business Overview
11.20.3 Pacific BioLabs Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.20.4 Pacific BioLabs Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.20.5 Pacific BioLabs Recent Developments
11.21 BA Sciences
11.21.1 BA Sciences Corporation Information
11.21.2 BA Sciences Business Overview
11.21.3 BA Sciences Antimicrobial Effectiveness Testing Service Product Features and Attributes
11.21.4 BA Sciences Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2020-2025)
11.21.5 BA Sciences Recent Developments
12 Antimicrobial Effectiveness Testing ServiceIndustry Chain Analysis
12.1 Antimicrobial Effectiveness Testing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Antimicrobial Effectiveness Testing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Antimicrobial Effectiveness Testing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Antimicrobial Effectiveness Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Antimicrobial Effectiveness Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Antimicrobial Effectiveness Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Antimicrobial Effectiveness Testing Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Antimicrobial Effectiveness Testing Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Antimicrobial Effectiveness Testing Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Antimicrobial Effectiveness Testing Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Antimicrobial Effectiveness Testing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Effectiveness Testing Service as of 2024)
 Table 11. Global Antimicrobial Effectiveness Testing Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Antimicrobial Effectiveness Testing Service Companies Headquarters
 Table 13. Global Antimicrobial Effectiveness Testing Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Antimicrobial Effectiveness Testing Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Antimicrobial Effectiveness Testing Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Antimicrobial Effectiveness Testing Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Antimicrobial Effectiveness Testing Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Antimicrobial Effectiveness Testing Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Antimicrobial Effectiveness Testing Service Growth Accelerators and Market Barriers
 Table 25. North America Antimicrobial Effectiveness Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Antimicrobial Effectiveness Testing Service Growth Accelerators and Market Barriers
 Table 27. Europe Antimicrobial Effectiveness Testing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Antimicrobial Effectiveness Testing Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Antimicrobial Effectiveness Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Antimicrobial Effectiveness Testing Service Investment Opportunities and Key Challenges
 Table 31. Central and South America Antimicrobial Effectiveness Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Antimicrobial Effectiveness Testing Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Antimicrobial Effectiveness Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Intertek Corporation Information
 Table 35. Intertek Description and Major Businesses
 Table 36. Intertek Product Features and Attributes
 Table 37. Intertek Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Intertek Revenue Proportion by Product in 2024
 Table 39. Intertek Revenue Proportion by Application in 2024
 Table 40. Intertek Revenue Proportion by Geographic Area in 2024
 Table 41. Intertek Antimicrobial Effectiveness Testing Service SWOT Analysis
 Table 42. Intertek Recent Developments
 Table 43. Eurofins Corporation Information
 Table 44. Eurofins Description and Major Businesses
 Table 45. Eurofins Product Features and Attributes
 Table 46. Eurofins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Eurofins Revenue Proportion by Product in 2024
 Table 48. Eurofins Revenue Proportion by Application in 2024
 Table 49. Eurofins Revenue Proportion by Geographic Area in 2024
 Table 50. Eurofins Antimicrobial Effectiveness Testing Service SWOT Analysis
 Table 51. Eurofins Recent Developments
 Table 52. Almac Corporation Information
 Table 53. Almac Description and Major Businesses
 Table 54. Almac Product Features and Attributes
 Table 55. Almac Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Almac Revenue Proportion by Product in 2024
 Table 57. Almac Revenue Proportion by Application in 2024
 Table 58. Almac Revenue Proportion by Geographic Area in 2024
 Table 59. Almac Antimicrobial Effectiveness Testing Service SWOT Analysis
 Table 60. Almac Recent Developments
 Table 61. Steris Corporation Information
 Table 62. Steris Description and Major Businesses
 Table 63. Steris Product Features and Attributes
 Table 64. Steris Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Steris Revenue Proportion by Product in 2024
 Table 66. Steris Revenue Proportion by Application in 2024
 Table 67. Steris Revenue Proportion by Geographic Area in 2024
 Table 68. Steris Antimicrobial Effectiveness Testing Service SWOT Analysis
 Table 69. Steris Recent Developments
 Table 70. Aemtek Corporation Information
 Table 71. Aemtek Description and Major Businesses
 Table 72. Aemtek Product Features and Attributes
 Table 73. Aemtek Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Aemtek Revenue Proportion by Product in 2024
 Table 75. Aemtek Revenue Proportion by Application in 2024
 Table 76. Aemtek Revenue Proportion by Geographic Area in 2024
 Table 77. Aemtek Antimicrobial Effectiveness Testing Service SWOT Analysis
 Table 78. Aemtek Recent Developments
 Table 79. Q Laboratories Corporation Information
 Table 80. Q Laboratories Description and Major Businesses
 Table 81. Q Laboratories Product Features and Attributes
 Table 82. Q Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Q Laboratories Recent Developments
 Table 84. Wickham Micro Corporation Information
 Table 85. Wickham Micro Description and Major Businesses
 Table 86. Wickham Micro Product Features and Attributes
 Table 87. Wickham Micro Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Wickham Micro Recent Developments
 Table 89. Nelson Labs Corporation Information
 Table 90. Nelson Labs Description and Major Businesses
 Table 91. Nelson Labs Product Features and Attributes
 Table 92. Nelson Labs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Nelson Labs Recent Developments
 Table 94. MycoScience Corporation Information
 Table 95. MycoScience Description and Major Businesses
 Table 96. MycoScience Product Features and Attributes
 Table 97. MycoScience Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. MycoScience Recent Developments
 Table 99. Reading Scientific Services Corporation Information
 Table 100. Reading Scientific Services Description and Major Businesses
 Table 101. Reading Scientific Services Product Features and Attributes
 Table 102. Reading Scientific Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Reading Scientific Services Recent Developments
 Table 104. MSL Solution Providers Corporation Information
 Table 105. MSL Solution Providers Description and Major Businesses
 Table 106. MSL Solution Providers Product Features and Attributes
 Table 107. MSL Solution Providers Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. MSL Solution Providers Recent Developments
 Table 109. Consumer Product Testing Company Corporation Information
 Table 110. Consumer Product Testing Company Description and Major Businesses
 Table 111. Consumer Product Testing Company Product Features and Attributes
 Table 112. Consumer Product Testing Company Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Consumer Product Testing Company Recent Developments
 Table 114. QACS Corporation Information
 Table 115. QACS Description and Major Businesses
 Table 116. QACS Product Features and Attributes
 Table 117. QACS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. QACS Recent Developments
 Table 119. Microchem Laboratory Corporation Information
 Table 120. Microchem Laboratory Description and Major Businesses
 Table 121. Microchem Laboratory Product Features and Attributes
 Table 122. Microchem Laboratory Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Microchem Laboratory Recent Developments
 Table 124. BioScreen Corporation Information
 Table 125. BioScreen Description and Major Businesses
 Table 126. BioScreen Product Features and Attributes
 Table 127. BioScreen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. BioScreen Recent Developments
 Table 129. Lucideon Corporation Information
 Table 130. Lucideon Description and Major Businesses
 Table 131. Lucideon Product Features and Attributes
 Table 132. Lucideon Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Lucideon Recent Developments
 Table 134. Microbac Corporation Information
 Table 135. Microbac Description and Major Businesses
 Table 136. Microbac Product Features and Attributes
 Table 137. Microbac Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Microbac Recent Developments
 Table 139. Pace Life Sciences Corporation Information
 Table 140. Pace Life Sciences Description and Major Businesses
 Table 141. Pace Life Sciences Product Features and Attributes
 Table 142. Pace Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Pace Life Sciences Recent Developments
 Table 144. Neopharm Corporation Information
 Table 145. Neopharm Description and Major Businesses
 Table 146. Neopharm Product Features and Attributes
 Table 147. Neopharm Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. Neopharm Recent Developments
 Table 149. Pacific BioLabs Corporation Information
 Table 150. Pacific BioLabs Description and Major Businesses
 Table 151. Pacific BioLabs Product Features and Attributes
 Table 152. Pacific BioLabs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 153. Pacific BioLabs Recent Developments
 Table 154. BA Sciences Corporation Information
 Table 155. BA Sciences Description and Major Businesses
 Table 156. BA Sciences Product Features and Attributes
 Table 157. BA Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 158. BA Sciences Recent Developments
 Table 159. Raw Materials Key Suppliers
 Table 160. Distributors List
 Table 161. Market Trends and Market Evolution
 Table 162. Market Drivers and Opportunities
 Table 163. Market Challenges, Risks, and Restraints
 Table 164. Research Programs/Design for This Report
 Table 165. Key Data Information from Secondary Sources
 Table 166. Key Data Information from Primary Sources


List of Figures
 Figure 1. Antimicrobial Effectiveness Testing Service Product Picture
 Figure 2. Global Antimicrobial Effectiveness Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. USP Standard Testing Product Picture
 Figure 4. EP Standard Testing Product Picture
 Figure 5. Global Antimicrobial Effectiveness Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Pharmaceutical
 Figure 7. Cosmetic
 Figure 8. Cleaning Supplies
 Figure 9. Others
 Figure 10. Antimicrobial Effectiveness Testing Service Report Years Considered
 Figure 11. Global Antimicrobial Effectiveness Testing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Antimicrobial Effectiveness Testing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Antimicrobial Effectiveness Testing Service Revenue Market Share by Region (2020-2031)
 Figure 15. Global Antimicrobial Effectiveness Testing Service Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. USP Standard Testing Revenue Market Share by Player in 2024
 Figure 18. EP Standard Testing Revenue Market Share by Player in 2024
 Figure 19. Global Antimicrobial Effectiveness Testing Service Revenue Market Share by Type (2020-2031)
 Figure 20. Global Antimicrobial Effectiveness Testing Service Revenue Market Share by Application (2020-2031)
 Figure 21. North America Antimicrobial Effectiveness Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 22. North America Top 5 Players Antimicrobial Effectiveness Testing Service Revenue (US$ Million) in 2024
 Figure 23. North America Antimicrobial Effectiveness Testing Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 24. North America Antimicrobial Effectiveness Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 25. US Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 26. Canada Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 27. Mexico Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 28. Europe Antimicrobial Effectiveness Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Europe Top 5 Players Antimicrobial Effectiveness Testing Service Revenue (US$ Million) in 2024
 Figure 30. Europe Antimicrobial Effectiveness Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 31. Europe Antimicrobial Effectiveness Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 32. Germany Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 33. France Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 34. U.K. Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 35. Italy Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 36. Russia Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Antimicrobial Effectiveness Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Top 8 Players Antimicrobial Effectiveness Testing Service Revenue (US$ Million) in 2024
 Figure 39. Asia-Pacific Antimicrobial Effectiveness Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Asia-Pacific Antimicrobial Effectiveness Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 41. Indonesia Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 42. Japan Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 43. South Korea Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 44. Australia Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 45. India Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 46. Indonesia Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 47. Vietnam Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 48. Malaysia Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 49. Philippines Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 50. Singapore Antimicrobial Effectiveness Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 51. Central and South America Antimicrobial Effectiveness Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Central and South America Top 5 Players Antimicrobial Effectiveness Testing Service Revenue (US$ Million) in 2024
 Figure 53. Central and South America Antimicrobial Effectiveness Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 54. Central and South America Antimicrobial Effectiveness Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Brazil Antimicrobial Effectiveness Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 56. Argentina Antimicrobial Effectiveness Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 57. Middle East and Africa Antimicrobial Effectiveness Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Middle East and Africa Top 5 Players Antimicrobial Effectiveness Testing Service Revenue (US$ Million) in 2024
 Figure 59. South America Antimicrobial Effectiveness Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Middle East and Africa Antimicrobial Effectiveness Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 61. GCC Countries Antimicrobial Effectiveness Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 62. Israel Antimicrobial Effectiveness Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 63. Egypt Antimicrobial Effectiveness Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 64. South Africa Antimicrobial Effectiveness Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 65. Antimicrobial Effectiveness Testing Service Industry Chain Mapping
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global In-service Inspection Services for Nuclear Facilities Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33X20008
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Marketing Work Management Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32Z20025
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Marketing Dashboard Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33J20012
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Industrial CT Inspection Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Q20225
Wed Dec 03 00:00:00 UTC 2025

Add to Cart